Foundation Venture Capital Group portfolio company receives significant NIH grant

New Brunswick, NJ—Actinobac Biomed Inc, originally funded with an investment from
Foundation Venture Capital Group, Inc., has received a $202,000 Small Business Technology
Transfer Grant (STTR) from the National Institutes of Health* to study its drug candidate,
Leukothera®, as a potential treatment for B-cell lymphomas.

Read more


Tags: , , ,

Categories: Life Sciences Industry Network

Author:NJ Tech Council

The New Jersey Tech Council helps companies grow and supports the tech, innovation and entrepreneurial ecosystems in the state and region.

NJTC TechWire

Daily updates about the region's most tech savvy companies

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: